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INTRODUCTION 
The traditional risk factors for atherosclerotic 
disease include age, gender, hypertension, 
smoking, body mass index, diabetes and 
hypercholesterolemia.[1] The female gender is 
considered a protective factor in the development 
of atherosclerosis.[2] Studies have shown that 
premenopausal women have more protective 
effect on the development of Coronary Heart 
Disease (CHD) when compared with both men of 
a similar age and postmenopausal women.[3-5]  
Estrogens affect the atherosclerotic process 
through a variety of mechanisms such as its  
lowering effect on total cholesterol and LDL-
C,[6,7] Lipoprotein (a),[8] and its increasing 
effect on HDL-C.[9-11] Estrogen also has both 
acute vasodilatory effect on the vessel wall and an 
atheroprotective effect involving inhibition of 
smooth-muscle cell proliferation.[12] 
The difference in cardiovascular risk between 
women and men at early ages disappears 
gradually after menopause and becomes equal for 
both sexes after ten years.[13-16] In this manner, 
cardiovascular diseases are considered to be the 
primary case of mortality in post-menopausal 
women.[17] Menopausal status is accompanied by 
unfavorable levels of cardiovascular risk factors, 
like changes in body fat, distribution from gynoid 
to android pattern, abnormal plasma lipids, 
increased sympathetic tone, endothelial 
dysfunction, vascular inflammation, and increased 
blood pressure.[18] Recently, postmenopausal 
women were reported to have the same prevalence 
of sub clinical carotids atherosclerosis as men 
matched with age and traditional risk factors.[19] 
Study also shows that oestrogen does not appear 
to provide a cardiovascular benefit in 
postmenopausal women with established coronary 
heart disease.[20] Moreover, it has been reported 
ABSTRACT 
Background: This study compared plasma lipids and glucose levels in hypertensive post-menopausal 
women with age-matched hypertensive men. Methods: This is a cross sectional study that involves 100 
subjects attending out-patient department of Nnamdi Azikiwe University Teaching hospital hypertensive 
clinics and control subjects. 25 hypertensive post-menopausal women and 25 hypertensive male subjects 
both within the same age range of 50-60 years. Also 25 hypertensive pre-menopausal women and 25 non-
hypertensive controls both within the age range of 30-40 years. The lipid profile parameters (Total 
Cholesterol (TC), Triglyceride (TG), Low density Lipoprotein (LDL-C), and High Density Lipoprotein 
(HDL-C)) and fasting plasma glucose were determined using standard methods. The study also assessed 
the anthropometric indices such as BMI, SBP and DBP in each group. Results: The mean levels of TC 
and TG were significantly lower in post-menopausal hypertensive females when compared with the 
hypertensive males (p<0.05). However, the mean plasma HDL-C and LDL-C did not show any significant  
difference between the two groups. The comparison of the mean levels of all the parameters in 
hypertensive males with the non-hypertensive controls showed a significant difference (P < 0.05). The 
mean levels of TC and LDL-C were significantly higher in hypertensive post-menopausal women when 
compared with hypertensive pre-menopausal females (P<0.05). Conclusion: This study showed that 
menopause had altered the plasma lipids of the hypertensive post-menopausal women, but not to the 
extent of putting them at the same atherosclerosis scale as their male counterpart.  
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that more post-menopausal female record an 
increased incidence of cardiovascular 
conditions.[17] The reason for this change in 
disease amongst women is not entirely clear, 
though however, it may be the observed 
association between atherosclerosis and 
hyperlipidemia. 
Today, more African women live beyond 50 
years, that is, post-menopause, a factor which 
should further heighten the risk of cardiovascular 
disease in them. As women age, their health is 
influenced by factors such as career, diet, physical 
activity level, the socioeconomic status and 
environment.[21] These changes, together with 
natural menopause, process of ageing, and 
hormonal changes in the reproductive system, 
affect the well-being of women.[22] The complex, 
interrelated nature of the process often makes it 
difficult to distinguish between the symptoms of 
ageing or those resulting from the loss of overian 
functions, and factors arising out of 
socioenvironmental conditions. Thus, we decided 
to compared men and women of the same age, 
traditional risk factors and socioeconomic and 
environmental status in other to ascertain their 
atherosclerosis status based on their lipid profile  
and glucose levels. It is hoped that the outcome of 
this study would improve our understanding of 
this growing subject and also help the 
management of menopause for which hormone 
replacement therapy is already being tried as a 
preventive measure against ischaemic heart 
disease arising from hyperlipidaemia.  
 
METHODS 
Study population and Design: 
A total of 100 subjects, comprising 25 
hypertensive post-menopausal women and 25 
hypertensive men, both within the age bracket of 
50-60yrs, and 25 hypertensive pre-menopausal 
women and 25 non hypertensive (men and 
women) both within the age bracket of 30-40yrs. 
They were all recruited after taking a thorough 
clinical history. Hypertensive women aged 
between 50 and 60 years, with absence of 
menstrual cycles for at least one year, were 
included. In all the groups, those that have any 
history of chronic illness, had undergone 
hysterectomy, and on hormone replacement 
therapy, were excluded from the study. The 
informed consent was obtained from all the 
participants, and the experimental protocol was 
approved by the Ethics committee of Nnamdi 
Azikiwe University Teaching Hospital, Nnewi.  
All the participants were instructed to refrain from 
food, alcohol and tobacco for 12 hours prior to 
recording and sample collection. They all 
underwent measurement of height, weight and 
basal blood pressure. Height was measured to the 
nearest 0.1 cm without footwear, using vertically 
movable scale. Weight was measured to the 
nearest 100 grams using a digital scale. A basal 
recording of blood pressure was done using 
Automatic Blood Pressure Monitor.  
Sample Collection and Biochemical Analysis 
5 mls of fasting venous blood samples were 
collected from all respondents for the analysis. A 
part was dispensed into fluoride oxalate bottles for 
glucose determination using standard enzymatic 
spectrophotometric method (Glucose Oxidase 
method). The remaining part was dispensed into a 
Na-EDTA bottle and the plasma separated and 
stored at -20ºC until analysis of Lipid profile. 
The total cholesterol (TC) was estimated using 
enzymatic endpoint method. The cholesterol is 
determined after enzymatic hydrolysis and 
oxidation. The indicator quinoneimine is formed 
from hydrogen peroxide and 4 - aminoantipyrine 
in the presence of phenol and peroxidase.  
High Density Lipoprotein (HDL) was estimated 
using enzymatic method. Low density lipoprotein 
(LDL and VLDL) and chylomicron fractions are 
precipitated quantitatively by the addition of 
phosphotungstic acid in the presence of 
magnesium ions. After centrifugation, the 
cholesterol concentration in the HDL fraction, 
which remains in the supernatant was determined.  
Triglyceride (TG) was estimated using enzymatic 
method. The triglycerides are determined after 
enzymatic hydrolysis with lipases. The indicator is 
a quinoneimine formed from hydrogen-peroxide, 
4-aminophenazone and 4-chlorophenol under the 
catalytic influence of peroxidase. 
Glucose was estimated using glucose oxidase 
method.  Glucose in plasma reacts with oxygen to 
give gluconic acid and hydrogen peroxide. This 
reaction is catalyzed by glucose oxidase enzyme. 
The hydrogen peroxide oxidizes the chromogen (4 
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- aminophenazone) in the presence of the enzyme 
peroxidase to give a colored compound that was 
measured spectrophotometrically.  
The LDL-C was calculated by the previously 
established formula of friedwald. Body mass indix 
was calculated from measured height and weight. 
The TC : HDL ratio and  averages (mean + SD) 
were determined. 
Statistical Analysis 
The version 20 of Statistical Package for Social 
Sciences (SPSS) was used in statistical analysis. 
All data were expressed as the mean ± standard 
deviations. The test of significant difference 
between two groups was done by the student T-
test with p<0.05 being the cut-off point of 
significant. 
 
 
 
RESULTS 
The comparison of the mean levels of parameters between the hypertensive post-menopausal women and 
those of their male counterparts showed significant difference (p<0.05) in levels of triglycerides and total 
cholesterol. However, the results showed no statistical significant difference in the levels of age, BMI, HDL-
C. LDL-C, TC: HDL, FBG, systolic BP, and diastolic BP in these two groups (Table 1).  
Table 1. The mean levels of some parameters in the Hypertensive post-menopausal women and those of 
their male counterpart. 
 
 
PARAMETE
RS 
POST– 
MENO 
(25) mean 
+ SD 
MALES 
(25)  
means + 
SD 
P 
=VALU
ES 
AGE (yrs) 57.68 + 
2.45 
57.80 + 
2.45 
1.000 
BMI (kgm־²) 28.51 + 
1.59 
26.60 + 
1.80 
0.080 
TC (mmoL/L) 5.21 + 
0.81 
5.92 + 
0.47 
0.004 
HDL-C 
(mmol/L) 
1.15 + 
0.32 
1.03 + 
0.28 
0.722 
LDL-C 
(mmol/L) 
3.37 + 
0.44 
4.06 + 
0.62 
0.388 
TG (mmol/L) 0.99 + 
0.04 
1.64 + 
0.36 
0.000 
TC : HDL 4.78 + 
1.13 
6.21 + 
1.90 
0.104 
FBG 
(mmol/L) 
5.39 + 
1.78 
5.8 + 2.75 0.829 
Systolic BP 
(mmHg) 
174.80 + 
15.08 
176.16 + 
20.82 
0.987 
Diastolic BP 
(mmHg) 
107.80 + 
13.03 
105.40 + 
15.06 
0.862 
 
 
The comparison of the mean levels of the parameters between the hypertensive post-menopausal women and 
those of hypertensive pre-menopausal women showed that there was statistical significant difference 
(p<0.05) between the mean levels of age, TC, LDL-C, FBG, systolic BP, and diastolic BP of the 
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hypertensive post-menopausal and that of hypertensive pre-menopausal women. The result also showed that 
there was no statistical significant different (p>0.05) between the mean levels of BMI, HDL-C, TC: HDL 
and FBG, of the hypertensive post-menopausal women and that of hypertensive pre-menopausal women 
(Table 2). 
Table 2. The mean levels of the some parameters of the hypertensive post-menopausal women and those of 
the hypertensive pre-menopausal women. 
 
PARAMETE
RS 
POST-
MENO 
(25) 
mean + 
SD 
PRE-
MENO 
(25)  
mean + SD 
P-
VALUE
S 
AGE (yrs) 57.68 + 
2.75 
38.68 + 
1.84 
0.000 
BMI (kgm־²) 28.51 + 
1.59 
26.75 + 
1.83 
0.123 
TC (mmol/L) 5.21 + 
0.81 
4.89 + 0.65 0.000 
HDL-C 
(mmol/L) 
1.15 + 
0.32 
1.25 + 0.37 0.826 
LDL-C 
(mmol/L) 
3.75 + 
0.44 
3.04 + 0.06 0.03 
TG (mmol/L) 0.99 + 
0.40 
1.65 + 0.62 0.000 
TC : HDL 4.78 + 
1.13 
4.21 + 1.29 0.795 
FBG 
(mmol/L) 
5.39 + 
1.78 
4.55 + 1.09 0.336 
Systolic BP 
(mmHg) 
174.80 + 
15.08 
150.52 + 
8.14 
0.000 
Diastolic BP 
(mmHg) 
107.80 + 
3.09 
93.64 + 
3.09 
0.000 
 
The comparison of the mean levels of the parameters between the hypertensive post-menopausal women and 
those of the non-hypertensive control individuals shows that there is statistical significance difference 
(p<0.05) between the mean levels of age, BMI, TC, HDL-C, LDL-C, systolic BP and diastolic BP of the 
hypertensive post-menopausal women and that of non-hypertensive control individuals. The result also 
shown that there were no statistical significant differences between the levels of TG, TC:HDL, and FBG of 
the hypertensive post-menopausal women and that of non-hypertensive control individuals (Table 3).  
Table: 3. The mean levels of some parameters of the hypertensive post-menopausal women and those of 
non-hypertensive control individuals.  
 
PARAME
TERS 
POST-
MENO  
N = 25 
CONTRO
L  
N = 25 
P-
VALU
E 
AGE (yrs) 57.68 + 2.75 43.00 + 
8.94 
0.000 
BMI 
(kgm־²) 
28.51 + 1.59 23.92 + 
4.68 
0.000 
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TC 
(mmol/L) 
5.21 + 0.81 4.50 + 0.86 0.004 
HDL-C 
(mmol/L) 
1.15 + 0.32 1.45 + 0.60 0.018 
LDL-C 
(mmol/L) 
3.75 + 0.44 2.25 + 1.01 0.000 
TG 
(mmol/L) 
0.99 + 0.04 1.22 + 0.54 0.354 
TC:HDL 4.78 + 1.13 3.97 + 3.58 0.569 
FBG 
(mmol/L) 
5.39 + 1.78 4.19 + 0.74 0.082 
SBP 
(mmHg) 
1.74.80+ 
15.08 
115.36 + 
952 
0.000 
DBP 
(mmHg) 
107.80 + 
13.03 
70.88 + 
7.94 
0.000 
 
The comparison of the mean levels of the parameters between the hypertensive males and those of the non-
hypertensive control individuals shows that there were statistical significant difference (p<0.05) between the 
mean levels of the all the parameters in hypertensive males and that of the non-hypertensive males control 
individuals (Table 4). 
Table 4. The mean levels of some parameters of the hypertensive males and those of the non-hypertensive 
control individuals. 
PARAMETE
RS 
MALES  
N = 25  
CONTROL
S  
N = 25  
P-
VALU
ES 
Age (yrs) 57.80 + 
2.45 
43.00 + 
8.94 
0.000 
BMI (kgm  ־ ²) 26.60 + 
1.80 
23.92 + 
4.68 
0.005 
TC (mmol/ 
L)  
5.92 + 
0.47 
4.50 + 0.86 0.000 
HDL-C 
(mmol/L) 
1.03 + 
0.28 
1.45 + 0.60 0.001 
LDL-C 
(mmol/L) 
4.06 + 
0.62 
2.25 + 1.01 0.000  
TG (mmol/L) 1.64 + 
0.36 
1.22 + 0.54 0.015 
TC:HDL 6.21 +  
1.90 
3.94 + 3.58 0.003 
FBG 
(mmol/L) 
5.82 + 
2.75 
4.19 + 0.74 0.008 
Systolic BP 
(mmHg) 
176.16 + 
20.82 
115.36 + 
9.52 
0.000 
Diastolic BP 
(mmHg) 
105.40 + 
7.94 
70.88 + 
7.94 
0.000 
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DISCUSSION 
This study showed that the levels of TG and TC are 
significantly lower in hypertensive post-menopausal 
women than in their male counterpart. This shows that 
there is a lower tendency for hypertensive post-
menopausal females to develop atheroma than males 
of their age. This outcome agrees with the situation 
reported in pre-menopausal hypertensive females, 
which showed that hypertensive child-bearing females 
stood less risk of atherosclerotic diseases, compared 
with men their age.[23] It also agrees with the findings 
in normal post-menopausal females, which reported 
that normal postmenopausal women, by plasma lipid 
analysis, stand less risk of atheroma-formation than 
their male counterparts.[24] 
The female gender already largely shields these 
females from the risk of atheroma formation.[2] To 
further favour the females, oestrogen is known to have 
an inverse relationship with plasma lipid level.[25] 
Estrogens affect the atherosclerotic process through a 
variety of mechanisms such as its lowering effect on 
total cholesterol and LDL,[6,7] Lipoprotein (a),[8] and 
its increasing effect on HDL.[9,10] Estrogen also has 
both acute vasodilatory effect on the vessel wall and an 
atheroprotective effect involving inhibition of smooth-
muscle cell proliferation.[12] Though menopause is 
associated with waning influence of oestrogen, 
aromatization in peripheral fatty tissues could partly 
sustain the oestrogen influence far into the 
postmenopausal period. This may be in operation in 
Nigeria females, with a BMI above pre-menopausal 
values. 
Furthermore, the comparison between hypertensive 
post-menopausal women and non-hypertensive 
controls, and also between hypertensive men and non-
hypertensive controls showed that both post-
menopausal women and their male counterpart are at 
risk of developing CHD but tends to be more among 
hypertensive men. This is because all the parameters 
analyzed in this study were significantly higher in 
hypertensive men than in non-hypertensive controls, 
while there is no significant difference in the mean 
levels of triglyceride, TC:HDL, and fasting plasma 
glucose in hypertensive post-menopausal women and 
non-hypertensive controls. Thus, putting the 
hypertensive post-menopausal women less in the 
atherosclerosis scale than their male counterpart. 
This study also showed that the level of LDL-C and 
cholesterol are significantly higher in hypertensive 
post-menopausal women than in hypertensive pre-
menopausal women. This is in line with some studies 
that showed that pre-menopausal women have more 
protective effect on the development of CHD when 
compared with both men of a similar age and 
postmenopausal women.[3,5] Factors that may partly 
explain the positioning of the post-menopausal women 
on the atheroma scale than pre-menopausal women 
would include age,[1] higher BMI, diminishing 
oestrogen effect[23] and duration of the hypertension.  
These findings supported our present study as our 
results showed significantly higher levels of BMI, 
SBP, DBP, and age in post-menopausal women than in 
pre-menopausal women. 
 
CONCLUSION 
In conclusion, this study showed that menopause had 
altered the plasma lipids of the hypertensive females, 
but not to the extent of putting them at  the same level 
of atherosclerosis risk scale as their male counterpart.  
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